SOSV's IndieBio x LOTTE Ventures U.S. JPM'25 - Leveraging the Global Landscape: New Pathways and Geographies in Drug Development

​We would be delighted to have you join us for our JPM Week ‘25 Panel Discussion and Mixer on January 15th, co-hosted by SOSV’s IndieBio and LOTTE Ventures U.S., supported by GQR.

​It has been the best of times and the worst of times for biotech investing, but precisely this climate of investor hesitation cuts away the fog of sector exuberance, and brings the best founders and science to light. Our theme for the afternoon is centered on smart ways of approaching therapeutics investing, leveraging geographic advantages and smart development pathways to make meaningful progress on the long road to market authorization.

​Given that the hulkingly huge problem of improving human health still remains unsolved, we at SOSV’s IndieBio and LOTTE Ventures U.S. remain committed to making courageous and smart investments in transformational therapeutics companies and partnering with our founders for the long term. We believe that precisely in this funding downturn, we will see generational companies develop game-changing drugs. What’s new? We think that the time for has come for overlooked strategies that enable exquisite capital efficiency and speed. We are excited to share some of our learnings with you and foster our community of value-oriented, mission-driven therapeutics founders and funders.

​Join us for our founder-investor meeting space and GQR office hours at 3 pm and our panel discussion followed by a hearty Korean-themed dinner from 4 pm onwards at CANOPY Jackson Square (a stone’s throw from the Transamerica Pyramid in downtown San Francisco). Please reach out if you would like to enjoy complimentary underground valet parking for the day!

​Please stay tuned for our panel line-up announcement and founder-investor meeting booking system.